Daily Medical Update

Chronic Pain Management (Multimodal, opioid sparing)

Thursday, March 12, 2026

🔬 Practice‑Changing Findings
Evidence from RCTs and meta‑analyses published in the last 12 months.

1. Opioid agonist therapy for opioid use disorder in primary versus specialty care.

Cochrane Database Syst Rev (2025) - Systematic Review/Meta-analysis

Key Findings

  • Across 7 randomized trials (n=1,952), treatment retention in primary care was similar to specialty care (RR 1.15, 95% CI 0.98-1.34).
  • Abstinence from non-prescribed opioids favored primary-care models in pooled analysis (RR 1.59, 95% CI 1.03-2.46).

📋 Practice Implication: Use primary care as a first-line access point for opioid-risk management when patients are clinically stable, rather than defaulting referral-only pathways.

2. Behavioral Therapy as an Adjunct to Buprenorphine Treatment for Opioid Use Disorder: A Secondary Analysis of 4 Randomized Clinical Trials.

JAMA Network Open (2025) - Secondary Analysis of RCTs

Key Findings

  • Adding behavioral therapy to buprenorphine plus medical management did not improve opioid-free weeks (B=0.28; 95% CI -0.33 to 0.89).
  • Adjunct behavioral therapy did not increase buprenorphine retention (B=0.00; 95% CI -0.43 to 0.43).

📋 Practice Implication: In resource-limited settings, prioritize rapid medication initiation and dependable follow-up instead of delaying care while arranging intensive psychotherapy.

3. Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): results of a 28-site cluster-randomized type 3 hybrid trial.

Implementation Science (2025) - Cluster RCT

Key Findings

  • Enhanced implementation support increased contingency-management exposure (OR 3.21) and high-fidelity competence (OR 4.07).
  • Patients at enhanced-support sites had higher odds of opioid abstinence over time (OR 2.04).

📋 Practice Implication: When rolling out opioid-sparing behavior programs, invest in facilitation and team-level implementation supports, not training alone.

4. Addiction Consult Services, Mortality, and Acute Care Utilization in Inpatients With Opioid Use Disorder: A Secondary Analysis of a Cluster Randomized Clinical Trial.

JAMA Network Open (2025) - Cluster RCT Secondary Analysis

Key Findings

  • Hospital addiction consult services reduced post-discharge emergency visits (IRR 0.79, 95% CI 0.72-0.88).
  • No significant reduction was seen for rehospitalization or all-cause mortality in the follow-up period.

📋 Practice Implication: After opioid-related hospitalization, build structured PCP transition contact within days of discharge to reduce recurrent acute-care use.

5. Oral methadone versus sublingual buprenorphine for the treatment of acute opioid withdrawal: A triple-blind, double-dummy, randomized control trial.

Drug and Alcohol Dependence (2025) - Randomized Controlled Trial

Key Findings

  • In inpatient withdrawal treatment, completion rates were equivalent with methadone and buprenorphine (82.5% vs 82.0%; p=0.95).
  • Methadone produced greater withdrawal-score improvement (COWS/SOWS; p=0.01), while adverse-effect rates were comparable.

📋 Practice Implication: Choose withdrawal agent based on which medication can be continued seamlessly into outpatient maintenance in your local network.

6. Age differences in demographic and clinical characteristics among veterans with chronic low back pain: baseline findings from the VERDICT trial.

Chiropractic & Manual Therapies (2025) - Pragmatic Trial Baseline Analysis

Key Findings

  • High-impact chronic pain prevalence was similar in younger vs older veterans (64.5% vs 62.2%), with comparable severe pain interference scores (63.8 vs 63.2).
  • Compared with older veterans, younger veterans had higher depression (44.8% vs 31.4%), anxiety (41.5% vs 20.7%), and PTSD (38.4% vs 17.6%) burden.

📋 Practice Implication: Pair non-opioid pain plans with age-stratified behavioral health screening intensity, especially for younger adults with chronic low back pain.

7. Impact of Cognitive Behavioral Therapy for Insomnia on Veterans' Willingness to Seek Treatment for Comorbid Health Conditions.

Behavioral Sleep Medicine (2025) - Randomized Controlled Trial

Key Findings

  • CBT-I increased willingness to seek insomnia treatment (d=0.86) and chronic pain treatment (d=0.60) versus sleep-hygiene control.
  • No significant willingness increase occurred for alcohol, depression, anxiety, or PTSD treatment pathways.

📋 Practice Implication: Integrate CBT-I into chronic pain workflows to improve uptake of non-pharmacologic pain care even when broader mental-health engagement remains unchanged.

💡 Summary

New evidence relevant to multimodal, opioid-sparing care emphasizes that primary-care-centered medication pathways, implementation quality, and coordinated follow-up can drive meaningful opioid-related outcomes. Recent randomized and meta-analytic studies suggest access and workflow design often matter more than adding high-intensity adjuncts by default. For chronic pain populations, integrating behavioral sleep care and psychosocial risk stratification remains important to improve engagement with non-opioid treatment plans.

Generated from 462 PubMed abstracts · RCTs and Meta‑analyses only

Next topic: Neuropathic Pain (Gabapentinoids, SNRIs, topicals)

Unsubscribe · Subscribe